Monthly 140 mg erenumab injections are a safe and effective treatment for patients with nonopioid chronic migraine and medication overuse headaches.

In patients with migraine, erenumab was safe and tolerable and effectively reversed migraine deterioration during treatment pauses.

Doctors and scientists believe migraine is due to "the result of abnormal brain activity affecting nerve signals, chemicals ...

Your head hurts. Maybe you were staring at your computer or phone too long. Or you skipped breakfast, didn’t sleep well, or got stressed fighting traffic. But now that it’s here, what can you do to ...

The drug provides an alternative to CGRP antagonists delivered by injection or infusion, like Novartis’ Aimovig (erenumab), Teva’s Ajovy (fremanezumab), Eli Lilly’s Emgality (galcanezumab ...

The decision means that with two CGRP antibodies now cleared for migraine prevention, the first drug in the class to be approved in Europe – Novartis’ Aimovig (erenumab) – has fallen further ...

Amit Shah vows anti-conversion law in Maharashtra, opposition caste census Union Home Minister Amit Shah, during the release of BJP's election manifesto in Mumbai, promised a stringent anti ...

Nov. 7, 2024 — Plastic pollution exacerbates the impacts of all planetary boundaries, including climate change, ocean acidification and biodiversity loss, a new paper shows. Ahead of the final ...

Nov. 1, 2024 — Microplastics have been steadily increasing in freshwater environments for decades and are directly tied to rising global plastic production since the 1950s, according to a new ...

CENTRAL GOVERNMENT FUNDS: Social welfare would account for the largest portion of the NT$3.33 trillion budget, followed by spending on education, tech and culture ...